Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data

Evaluation of Dementia Rating Scales in Parkinson’s Disease Dementia

(2009) Philip D. Harvey et al.   American Journal of Alzheimers Disease and Other Dementias

Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease Dementia

(2009) Wolfgang Oertel et al.   DRUG SAFETY

The epidemiology of dementia associated with Parkinson disease

(2009) Dag Aarsland et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Progression from mild cognitive impairment to Alzheimerʼs disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment

(2009) Steven Ferris et al.   Pharmacogenetics and Genomics

Parkinson's disease: clinical features and diagnosis

(2008) J Jankovic   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients

(2008) Paolo Barone et al.   MOVEMENT DISORDERS

Basic Research on Dopamine in Parkinson’s Disease and the Discovery of the Nigrostriatal Dopamine Pathway: The View of an Eyewitness

(2008) Oleh Hornykiewicz   Neurodegenerative Diseases

Dementia and survival in Parkinson disease: A 12-year population study

(2008) T. C. Buter et al.   NEUROLOGY